Review



antibodies against phospho specific stat3 p stat3  (Cell Signaling Technology Inc)


Bioz Verified Symbol Cell Signaling Technology Inc is a verified supplier
Bioz Manufacturer Symbol Cell Signaling Technology Inc manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    Cell Signaling Technology Inc antibodies against phospho specific stat3 p stat3
    Expression of <t>Stat3</t> phosphorylation <t>(Tyr705)</t> in ( A ) endometrial cancer tissues and ( B ) cervical cancer tissues. Endometrial and cervical cancer tissue microarray slides were stained using IHC methods and an IHC-validated phospho-specific Stat3 antibody (Tyr705). The representative examples of phosphorylated Stat3 staining in normal tissues and positive staining of endometrial cancer tissues (grades I, II and III) are shown. The representative examples of phosphorylated Stat3 staining in normal tissues and positive staining of cervical cancer tissues (different stages) are shown.
    Antibodies Against Phospho Specific Stat3 P Stat3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 6975 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho-specific+protein+microarray+analysis/Phospho-Stat3+(Tyr705)+Antibody/pmc02360038-53-0-18
    Average 96 stars, based on 6975 article reviews
    antibodies against phospho specific stat3 p stat3 - by Bioz Stars, 2026-10
    96/100 stars

    Images

    1) Product Images from "Stat3 activation in human endometrial and cervical cancers"

    Article Title: Stat3 activation in human endometrial and cervical cancers

    Journal: British Journal of Cancer

    doi: 10.1038/sj.bjc.6603597

    Expression of Stat3 phosphorylation (Tyr705) in ( A ) endometrial cancer tissues and ( B ) cervical cancer tissues. Endometrial and cervical cancer tissue microarray slides were stained using IHC methods and an IHC-validated phospho-specific Stat3 antibody (Tyr705). The representative examples of phosphorylated Stat3 staining in normal tissues and positive staining of endometrial cancer tissues (grades I, II and III) are shown. The representative examples of phosphorylated Stat3 staining in normal tissues and positive staining of cervical cancer tissues (different stages) are shown.
    Figure Legend Snippet: Expression of Stat3 phosphorylation (Tyr705) in ( A ) endometrial cancer tissues and ( B ) cervical cancer tissues. Endometrial and cervical cancer tissue microarray slides were stained using IHC methods and an IHC-validated phospho-specific Stat3 antibody (Tyr705). The representative examples of phosphorylated Stat3 staining in normal tissues and positive staining of endometrial cancer tissues (grades I, II and III) are shown. The representative examples of phosphorylated Stat3 staining in normal tissues and positive staining of cervical cancer tissues (different stages) are shown.

    Techniques Used: Expressing, Phospho-proteomics, Microarray, Staining

    ( A ) Expression of Stat3, Stat1 and Stat5 phosphorylation in human immortalised cervical cell line (Ect1/E6E7) and cervical and endometrial cancer cell lines. A total of 100 μ g of total protein of cell lysates from various cell lines were resolved on 8% SDS–PAGE and subjected to Western blot analysis using antibodies that recognise phospho-specific Stat3 (Tyr705), Stat3 (Ser727), Stat1 (Tyr701), Stat5 (Tyr694), and GAPDH, respectively. ( B ) Densitometric quantitation of phospho-Stat3 (Tyr705) and Stat3 (Ser727) expressions. The phospho-Stat3 expressions are normalised to GAPDH expression in each cell line and shown in percentage of phospho-Stat3 (Tyr705) in SiHa cells and phospho-Stat3 (Ser727) in RL95-2 cells, respectively.
    Figure Legend Snippet: ( A ) Expression of Stat3, Stat1 and Stat5 phosphorylation in human immortalised cervical cell line (Ect1/E6E7) and cervical and endometrial cancer cell lines. A total of 100 μ g of total protein of cell lysates from various cell lines were resolved on 8% SDS–PAGE and subjected to Western blot analysis using antibodies that recognise phospho-specific Stat3 (Tyr705), Stat3 (Ser727), Stat1 (Tyr701), Stat5 (Tyr694), and GAPDH, respectively. ( B ) Densitometric quantitation of phospho-Stat3 (Tyr705) and Stat3 (Ser727) expressions. The phospho-Stat3 expressions are normalised to GAPDH expression in each cell line and shown in percentage of phospho-Stat3 (Tyr705) in SiHa cells and phospho-Stat3 (Ser727) in RL95-2 cells, respectively.

    Techniques Used: Expressing, Phospho-proteomics, SDS Page, Western Blot, Quantitation Assay

    The association of p-Stat3 (Tyr705) with the expression of p-Stat3 (Ser727) and potential Stat3 downstream targets in endometrial carcinomas
    Figure Legend Snippet: The association of p-Stat3 (Tyr705) with the expression of p-Stat3 (Ser727) and potential Stat3 downstream targets in endometrial carcinomas

    Techniques Used: Expressing, Immunohistochemistry

    The association of p-Stat3 (Tyr705) with the expression of p-Stat3 (Ser727) and potential Stat3 downstream targets in cervical carcinomas
    Figure Legend Snippet: The association of p-Stat3 (Tyr705) with the expression of p-Stat3 (Ser727) and potential Stat3 downstream targets in cervical carcinomas

    Techniques Used: Expressing, Immunohistochemistry

    Transduction of dnStat3 inhibits cell growth and viability in cervical cancer cell lines. ( A ) Expression of dnStat3 mediated by rAd vector in a dose-dependent manner in HeLa and SiHa cervical cancer cell lines. One hundred micrograms of cell lysates were analysed on 10% PAGE analysis and then subjected to immunoblots probed with anti-FLAG, -Stat3 and – GAPDH antibodies. The dose-dependent expression of FLAG-tagged dnStat3 is according to the increased expression levels of total Stat3 protein. There was no detectable FLAG-tagged dnStat3 in cell lysates of untransduced or cells transduced with rAd/eGFP. ( B ) and ( C ) dnStat3 inhibits HeLa and SiHa cell growth. HeLa and SiHa cells were transduced with either rAd/dnStat3 or rAd/eGFP (MOI=10–400). Representative phase-contrast images of HeLa and SiHa cells 48 h post-transduction were shown at magnification × 100. Only representative data (MOI=400) are shown for cells transduced with rAd/eGFP for cells transduced with MOI lower than 400 showed no adverse effects on cell growth. Cells in five random individual microscopic fields (× 100) were scored on day 2 post-transduction of rAd/eGFP or rAd/dnStat3. The cell growth is shown in cell density/control (%). The averages and standard deviations are based on triplicate independent experiments. ( D ) dnStat3 reduces cell viability of cancer cells with elevated phospho-Stat3 at 48 h post-transduction. HeLa and Ishikawa cells were transduced with rAd/eGFP and rAd/dnStat3 (MOI=250). Cell viability was analysed using MTT assay.
    Figure Legend Snippet: Transduction of dnStat3 inhibits cell growth and viability in cervical cancer cell lines. ( A ) Expression of dnStat3 mediated by rAd vector in a dose-dependent manner in HeLa and SiHa cervical cancer cell lines. One hundred micrograms of cell lysates were analysed on 10% PAGE analysis and then subjected to immunoblots probed with anti-FLAG, -Stat3 and – GAPDH antibodies. The dose-dependent expression of FLAG-tagged dnStat3 is according to the increased expression levels of total Stat3 protein. There was no detectable FLAG-tagged dnStat3 in cell lysates of untransduced or cells transduced with rAd/eGFP. ( B ) and ( C ) dnStat3 inhibits HeLa and SiHa cell growth. HeLa and SiHa cells were transduced with either rAd/dnStat3 or rAd/eGFP (MOI=10–400). Representative phase-contrast images of HeLa and SiHa cells 48 h post-transduction were shown at magnification × 100. Only representative data (MOI=400) are shown for cells transduced with rAd/eGFP for cells transduced with MOI lower than 400 showed no adverse effects on cell growth. Cells in five random individual microscopic fields (× 100) were scored on day 2 post-transduction of rAd/eGFP or rAd/dnStat3. The cell growth is shown in cell density/control (%). The averages and standard deviations are based on triplicate independent experiments. ( D ) dnStat3 reduces cell viability of cancer cells with elevated phospho-Stat3 at 48 h post-transduction. HeLa and Ishikawa cells were transduced with rAd/eGFP and rAd/dnStat3 (MOI=250). Cell viability was analysed using MTT assay.

    Techniques Used: Transduction, Expressing, Plasmid Preparation, Western Blot, Control, MTT Assay

    Transduction of dnStat3 induces apoptosis through caspase 3 pathway in ( A ) HeLa and ( B ) SiHa cervical cancer cell lines day 2 post-transduction. Cells were transduced with rAd/dnStat3 or rAd/eGFP (MOI=400). Cells incubated with JSI-124 (5 and 10 μ M ), a Stat3 inhibitor, and DMSO served as a positive and negative control, respectively. Cells were fixed in methanol/acetone (v : v=1 : 1) and then immunostained with anti-cleaved caspase-3 antibody after 48 h. Cleaved caspase-3 immunoreactivies were observed in cells transduced with rAd/dnStat3, but much less in cells transduced with rAd/eGFP or the untransduced controls. Magnifications of all images were × 100. The percentages of cleaved caspase-3 positive cells were scored in five microscopic fields. The averages and standard deviations are based on three independent experiments. ( C ) dnStat3 induces cleavage of PARP in HeLa and SiHa cell lines. HeLa and SiHa cells were transduced with rAd/dnStat3 and rAd/eGFP (MOI:10, 100 and 400). After 48 h, cell lysates (100 μ g) were fractionated using SDS–PAGE and subject to Western blots probed with anti-cleaved PARP and -GAPDH antibodies. Cleaved caspase 3: anticleaved-caspase-3 antibody immunofluorescent staining; DAPI: nuclear staining with DAPI; none: untransduced cells.
    Figure Legend Snippet: Transduction of dnStat3 induces apoptosis through caspase 3 pathway in ( A ) HeLa and ( B ) SiHa cervical cancer cell lines day 2 post-transduction. Cells were transduced with rAd/dnStat3 or rAd/eGFP (MOI=400). Cells incubated with JSI-124 (5 and 10 μ M ), a Stat3 inhibitor, and DMSO served as a positive and negative control, respectively. Cells were fixed in methanol/acetone (v : v=1 : 1) and then immunostained with anti-cleaved caspase-3 antibody after 48 h. Cleaved caspase-3 immunoreactivies were observed in cells transduced with rAd/dnStat3, but much less in cells transduced with rAd/eGFP or the untransduced controls. Magnifications of all images were × 100. The percentages of cleaved caspase-3 positive cells were scored in five microscopic fields. The averages and standard deviations are based on three independent experiments. ( C ) dnStat3 induces cleavage of PARP in HeLa and SiHa cell lines. HeLa and SiHa cells were transduced with rAd/dnStat3 and rAd/eGFP (MOI:10, 100 and 400). After 48 h, cell lysates (100 μ g) were fractionated using SDS–PAGE and subject to Western blots probed with anti-cleaved PARP and -GAPDH antibodies. Cleaved caspase 3: anticleaved-caspase-3 antibody immunofluorescent staining; DAPI: nuclear staining with DAPI; none: untransduced cells.

    Techniques Used: Transduction, Incubation, Negative Control, SDS Page, Western Blot, Staining

    Related Articles

    Western Blot:

    Article Title: Microglial Inhibition Promotes Proliferation and Differentiation of Neural Stem Cells via STAT3/SDF-1/CXCR4 Signaling Pathway in Hypoxic-Ischemic Encephalopathy.
    Article Snippet: .. The primary antibodies used for western blotting were as follows: STAT3 antibody (1:1000; Abcam, ab68153), PhosphoSTAT3 (Tyr705) antibody (1:1000; CST, #9145T), CXCR4 antibody (1:1000; Abcam, ab124824), iNOS antibody (1:1000; Abcam, ab283655), Arg- 1 antibody (1:1000; Abcam, ab233548), β- actin (1:1000; CST, #4970). .. Secondary antibodies included HRP- goat anti- rabbit IgG (1:5000; Biodragon, BF03008), and HRP- goat anti- mouse IgG (1:5000; Biodragon, BF03009).

    Blocking Assay:

    Article Title: Reduced IL10 expression in diminished ovarian reserve and receptor-dependent IL-10 responses in granulosa cell models
    Article Snippet: .. After blocking with 5% BSA in TBST, Membranes were incubated overnight at 4°C with primary antibodies against phospho-STAT3 (Tyr705; CST; #9145), total STAT3 (CST; #9139), and either β-actin (CST; #4970) or GAPDH (Proteintech; HRP−60004), as indicated, with β-actin or GAPDH serving as the loading control, Membranes incubated with unconjugated primary antibodies were subsequently incubated with the appropriate HRP-conjugated secondary antibodies (CST; #7074). .. Bands were visualized using enhanced chemiluminescence reagents (Epizyme; SQ101) and imaged on a chemiluminescence detection system (e-BLOT Life Science, Touch imager).

    Incubation:

    Article Title: Reduced IL10 expression in diminished ovarian reserve and receptor-dependent IL-10 responses in granulosa cell models
    Article Snippet: .. After blocking with 5% BSA in TBST, Membranes were incubated overnight at 4°C with primary antibodies against phospho-STAT3 (Tyr705; CST; #9145), total STAT3 (CST; #9139), and either β-actin (CST; #4970) or GAPDH (Proteintech; HRP−60004), as indicated, with β-actin or GAPDH serving as the loading control, Membranes incubated with unconjugated primary antibodies were subsequently incubated with the appropriate HRP-conjugated secondary antibodies (CST; #7074). .. Bands were visualized using enhanced chemiluminescence reagents (Epizyme; SQ101) and imaged on a chemiluminescence detection system (e-BLOT Life Science, Touch imager).

    Article Title: Exploring the immunomodulatory effects of environmental contaminants on autoimmune patients: An in vitro approach
    Article Snippet: Equal protein amounts were denatured, separated by 12 % SDS-PAGE, and transferred onto 0.45 μm PVDF membranes (Merck-Millipore, Burlington, MA, USA). .. Membranes were blocked with 5 % non-fat milk in TBS-T and incubated overnight at 4 °C with primary antibodies against phospho-AKT (Thr308), phospho-NFκB p65 (Ser536), phospho-p38 MAPK (Thr180/Tyr182), phospho-STAT1 (Tyr701), and phospho-STAT3 (Tyr705) (Cell Signaling Technology, Danvers, MA, USA; Santa Cruz Biotechnology, Dallas, TX, USA). .. Following washes, membranes were incubated with HRP-conjugated secondary antibodies, and signals were detected using PierceTM ECL substrate (Thermo Scientific, Waltham, MA, USA) on a ChemiDocTM MP imaging system (Bio-Rad, Hercules, CA, USA).

    Article Title: Role of STAT1 in modulating the host immune response to Plasmodium yoelii 17XL-infected murine blood-stage malaria.
    Article Snippet: .. Primary antibodies against STAT1, p-STAT1, STAT3, and pSTAT3 (Cell Signaling Technology, USA) were incubated with the membrane at a 1:1,000 dilution overnight at 4°C. .. A horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody (Southern Biotech, USA) was used for detection at a 1:5,000 dilution for 1 h at room temperature (RT).

    Control:

    Article Title: Reduced IL10 expression in diminished ovarian reserve and receptor-dependent IL-10 responses in granulosa cell models
    Article Snippet: .. After blocking with 5% BSA in TBST, Membranes were incubated overnight at 4°C with primary antibodies against phospho-STAT3 (Tyr705; CST; #9145), total STAT3 (CST; #9139), and either β-actin (CST; #4970) or GAPDH (Proteintech; HRP−60004), as indicated, with β-actin or GAPDH serving as the loading control, Membranes incubated with unconjugated primary antibodies were subsequently incubated with the appropriate HRP-conjugated secondary antibodies (CST; #7074). .. Bands were visualized using enhanced chemiluminescence reagents (Epizyme; SQ101) and imaged on a chemiluminescence detection system (e-BLOT Life Science, Touch imager).

    other:


    Article Title: CD16a/CD163 bispecific antibody-guided PPARγLNPs reprogram heterogeneous alveolar macrophages for the reversal of pathological airway remodeling
    Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER and APPLICATIONS Antibodies anti-PPARγ CST Cat# 2435s ;WB:1:1000; IF:1:200 anti-iNOS Affinity Cat#AF0199; WB:1:1000;IF:1:100 anti-CD16 Abmart Cat#TB5878,IHC 1:100 anti-CD163 Abmart Cat#PC2527S; WB:1:1000;IF:1:100, IHC 1:100 anti-vimentin proteintech Cat#60330; WB:1:20000;IF:1:500 anti-CD31 proteintech Cat#11265-1-AP; IF:1:100; anti-E-cadherin Affinity Cat#AF0131; WB:1:1000 anti-N-cadherin Affinity Cat#AF5239; WB:1:1000 anti-gapdh Affinity Cat#AF7021; WB:1:10000 anti-CD68 CST Cat#E3O7V;IF:1:400 anti-PPARγ proteintech Cat#66936-1-Ig; IF:1:100 anti-sirt1 Cohesion Cat#CQA2569; WB:1:1000 anti-CPT1A Abmart Cat#TB3581S; WB:1:1000;IF:1:100 anti-CD36 Abmart Cat#T55796S; WB:1:1000 anti-GLUT1 Abmart Cat#T55360; WB:1:1000 anti-HIF-1α Affinity Cat#BF8002;WB:1:1000 anti-HK2 Abmart Cat#P55312R2; WB:1:1000 anti-PKM2 Affinity Cat#AF3328; WB:1:1000 anti-β-actin Affinity Cat#T0022; WB:1:10000 anti-PGC-1α Abmart Cat#T56630; WB:1:1000 anti-NRF2 CST Cat#12721T; WB:1:1000 anti-NRF1 Affinity Cat#AF5298; WB:1:1000 anti-AMPK CST Cat#2532S;WB:1:1000 (continued on next column) (continued ) REAGENT or RESOURCE SOURCE IDENTIFIER and APPLICATIONS anti-phospho-AMPK CST Cat#2535S;WB:1:1000 anti-mTOR CST Cat#2983S;WB:1:1000 anti-phospho-mTOR CST Cat#5536S;WB:1:1000 anti-4E-BP1 CST Cat#9452S;WB:1:1000 anti-phospho-4E-BP1 CST Cat#236B4;WB:1:1000 anti-S6K CST Cat#34475T; WB:1:1000 anti-phospho-S6K CST Cat#9234S;WB:1:1000 anti-CD86 CST Cat#91882T; WB:1:1000 anti-IL-1β Abmart Cat#PC6319; WB:1:1000 anti-TNF-α Proteintech Cat#80258-6; WB:1:2000 anti-Arg1 Proteintech Cat#66129-1-Ig; WB:1:1000;IF:1:100 anti-JAK1 Proteintech Cat#66466-1-Ig; WB:1:1000 anti-phospho-JAK1 Affinity Cat#AF2012; WB:1:1000 anti-STAT1 Affinity Cat#DF6001; WB:1:1000 anti-phospho-STAT1 Affinity Cat#AF3300; WB:1:1000 anti-STAT3 Cohesion Cat#CPA2114; WB:1:1000 anti-phospho-STAT3 CST Cat#9131S;WB:1:1000 anti-STAT6 Affinity Cat#AF3301; WB:1:1000 anti-phospho-STAT6 CST Cat#56554T; WB:1:1000 anti-P65 Affinity Cat#AF5006; WB:1:1000 anti-phospho-P65 Affinity Cat#AF2006; WB:1:1000 anti-P38 Cohesion Cat#CPA5094; WB:1:1000 anti-phospho-P38 Affinity Cat#AF4001; WB:1:1000 anti-AKT1/2/3 Affinity Cat#AF6261; WB:1:1000 anti-phospho-AKT1/2/3 Affinity Cat#AF0016; WB:1:1000 anti-foxo1 Abmart Cat#PA5293; WB:1:1000 anti-phospho-foxo1 Abmart Cat#TA3416; WB:1:1000 anti-TAK1 Proteintech Cat#12330-AP; WB:1:1000 anti-phospho-TAK1 Proteintech Cat#28958-1-AP; WB:1:1000 anti-phospho-ERK1/2 Affinity Cat#AF1015; WB:1:1000 (continued on next page) Fig. 8.

    Membrane:

    Article Title: Role of STAT1 in modulating the host immune response to Plasmodium yoelii 17XL-infected murine blood-stage malaria.
    Article Snippet: .. Primary antibodies against STAT1, p-STAT1, STAT3, and pSTAT3 (Cell Signaling Technology, USA) were incubated with the membrane at a 1:1,000 dilution overnight at 4°C. .. A horseradish peroxidase (HRP)-conjugated goat anti-rabbit IgG secondary antibody (Southern Biotech, USA) was used for detection at a 1:5,000 dilution for 1 h at room temperature (RT).



    Similar Products

    phospho-specific protein microarray analysis tyrosine phosphorylation proarray  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho-specific protein microarray analysis tyrosine phosphorylation proarray
    Effect of Lem4 on tyrosine <t>phosphorylation</t> of signal proteins in HEK293T cell line, as detected by tyrosine phosphorylation <t>ProArray</t> (Full Moon BioSystems). Phosphorylation levels were increased by at least 30% at 30 sites and decreased by at least 30% at four sites in the cells overexpressing Lem4-GFP. Red dashed line indicates the level of phosphorylation in the control GFP-expressing cell line.
    Phospho Specific Protein Microarray Analysis Tyrosine Phosphorylation Proarray, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho-specific+protein+microarray+analysis/tyrosine+phosphorylation+proarray/pmc06109923-513-0-10
    Average 90 stars, based on 1 article reviews
    phospho-specific protein microarray analysis tyrosine phosphorylation proarray - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier
    phospho-specific protein microarray analysis  (Full Moon BioSystems)
    90
    Full Moon BioSystems phospho-specific protein microarray analysis
    Effect of Lem4 on tyrosine <t>phosphorylation</t> of signal proteins in HEK293T cell line, as detected by tyrosine phosphorylation <t>ProArray</t> (Full Moon BioSystems). Phosphorylation levels were increased by at least 30% at 30 sites and decreased by at least 30% at four sites in the cells overexpressing Lem4-GFP. Red dashed line indicates the level of phosphorylation in the control GFP-expressing cell line.
    Phospho Specific Protein Microarray Analysis, supplied by Full Moon BioSystems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/phospho-specific+protein+microarray+analysis/phospho+explorer+antibody+array/pmc02596073-546-17-9
    Average 90 stars, based on 1 article reviews
    phospho-specific protein microarray analysis - by Bioz Stars, 2026-10
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Effect of Lem4 on tyrosine phosphorylation of signal proteins in HEK293T cell line, as detected by tyrosine phosphorylation ProArray (Full Moon BioSystems). Phosphorylation levels were increased by at least 30% at 30 sites and decreased by at least 30% at four sites in the cells overexpressing Lem4-GFP. Red dashed line indicates the level of phosphorylation in the control GFP-expressing cell line.

    Journal: The Journal of Biological Chemistry

    Article Title: Legionella pneumophila effector Lem4 is a membrane-associated protein tyrosine phosphatase

    doi: 10.1074/jbc.RA118.003845

    Figure Lengend Snippet: Effect of Lem4 on tyrosine phosphorylation of signal proteins in HEK293T cell line, as detected by tyrosine phosphorylation ProArray (Full Moon BioSystems). Phosphorylation levels were increased by at least 30% at 30 sites and decreased by at least 30% at four sites in the cells overexpressing Lem4-GFP. Red dashed line indicates the level of phosphorylation in the control GFP-expressing cell line.

    Article Snippet: Phospho-specific protein microarray analysis Tyrosine phosphorylation ProArray was purchased from Full Moon Biosystems (Sunnyvale, CA).

    Techniques: Phospho-proteomics, Control, Expressing